Skip to main content

Arax Advisory Partners

Position in NBIX — Neurocrine Biosciences Inc

CIK 1586767 DENVER, CO

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$188,651
+$134,614 QoQ
Shares Held
1,432
+275.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Arax Advisory Partners holds $1,784,999 across 41 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (10.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
1,432 $188,651

All Filings in NBIX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $188,651 1,432
2025-12-31 $54,037 381
2025-09-30 $5,662,086 40,334
2025-06-30 $15,711 125
2025-03-31 $14,378 130
2024-12-31 $72,891 534
2024-09-30 $90,102 782
2024-06-30 $107,657 782
2024-03-31 $5,930 43
2023-12-31 $5,665 43
2023-09-30 $5,174 46
2023-06-30 $3,489 37
2023-03-31 $4,656 46
2022-12-31 $5,494 46
2022-09-30 $4,885 46
2022-06-30 $3,606 37
2022-03-31 $3,468 37